AdaptHealth AHCO
NASDAQ AHCO
$5.41 -0.25 (-4.51%)
As of: Aug 20, 2026 · 3:59 PM EDT

AdaptHealth (AHCO) Asset Writedowns and Impairment (2019 - 2026)

AdaptHealth (AHCO) posted quarterly Asset Writedowns and Impairment of $691000.0 for Q1 2026, down 50.64% quarter-over-quarter from $1.4 million in Q2 2021.

AdaptHealth (AHCO) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends

AdaptHealth's Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $691000.0 for Q1 2026.

  • In Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $691000.0; the TTM figure through Mar 2026 stood at $2.1 million (down 62.75% YoY), while the FY2021 annual figure was $4.1 million, down 23.74% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $691000.0, down from $1.4 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $691000.0 in Q1 2026, with the low at $691000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 AdaptHealth 730.28 Mn 686.99 Mn 104.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 487,000.00
Jun 30, 2026 487,000.00
Mar 31, 2026 691,000.00
Mar 31, 2026 691,000.00
Jun 30, 2021 1.40 Mn
Jun 30, 2021 1.40 Mn
Mar 31, 2021 4.21 Mn
Mar 31, 2021 4.21 Mn
Dec 31, 2020 5.27 Mn
Dec 31, 2020 5.27 Mn
Sep 30, 2020 5.30 Mn
Sep 30, 2020 5.30 Mn
Sep 30, 2019 21,000.00
Sep 30, 2019 21,000.00
Mar 31, 2019 2.10 Mn
Mar 31, 2019 2.10 Mn